Eric I. Richman

Companies

• Gain Therapeutics, Inc.Board member Aug 17, 2021 to now¹
• NeuBase Therapeutics, Inc.Board member Jul 16, 2019 to Sep 12, 2022²
• Gain Therapeutics, Inc.Chief executive officer Mar 17, 2021 to May 27, 2022³
• ADMA Biologics (United States)Board member Feb 15, 2012 to Mar 3, 2020⁴
• Altimmune, Inc.Board member May 20, 2010 to Nov 23, 2016⁵
• Altimmune, Inc.Chief executive officer May 20, 2010 to Dec 15, 2014⁵
• Altimmune, Inc.President May 20, 2010 to Dec 15, 2014⁵
• Altimmune, Inc.Sr. VP, Business Development Aug 17, 2007 to Mar 8, 2012⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GTGain Therapeutics, Inc. GANX304,458 shares⁷$404.9K at $1.33Jul 1, 2024
• NTNeuBase Therapeutics, Inc.72,707 shares⁸Mar 7, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 1, 2024Bought 12,000 shares at $1.21 of Gain Therapeutics, Inc.⁷
• Jul 1, 2024Bought 5,000 shares at $1.23 of Gain Therapeutics, Inc.⁷
• Sep 20, 2023Exercised options 54,900 shares of Gain Therapeutics, Inc.⁹
• May 25, 2022Bought 2,482 shares at $2.58 of Gain Therapeutics, Inc.¹⁰
• May 20, 2022Bought 9,256 shares at $2.83 of Gain Therapeutics, Inc.¹¹
• May 19, 2022Bought 4,000 shares at $2.71 of Gain Therapeutics, Inc.¹¹
• Mar 4, 2022Bought 1,000 shares at $1.62 of NeuBase Therapeutics, Inc.⁸
• Mar 3, 2022Bought 1,300 shares at $1.72 of NeuBase Therapeutics, Inc.⁸
• Mar 1, 2022Bought 1,580 shares at $1.58 of NeuBase Therapeutics, Inc.⁸
• Aug 16, 2021Bought 4,922 shares at $7.87 of Gain Therapeutics, Inc.¹²